Literature DB >> 2001814

Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure.

D H Berman1, R I Leventhal, J S Gavaler, E M Cadoff, D H Van Thiel.   

Abstract

Establishing a diagnosis of fulminant Wilson's disease can be difficult because Kayser-Fleischer rings may not be present and parameters of copper metabolism, including serum and urinary copper, and serum ceruloplasmin levels are neither specific nor diagnostic. In this study, ratios of both the serum alkaline phosphatase to total bilirubin and aspartate transaminase to alanine transaminase were constructed to evaluate their usefulness in differentiating fulminant hepatic failure caused by Wilson's disease (n = 6) from other etiologies (n = 43). An analysis of the data showed that cutoff values of less than 2.0 for the alkaline phosphatase-total bilirubin ratio and greater than 4.0 for the aspartate transaminase ratio were associated with a diagnosis of fulminant hepatic failure caused by Wilson's disease only (P less than 0.001). The alkaline phosphatase-total bilirubin ratio of less than 2.0 provided 100% sensitivity and specificity in identifying fulminant hepatic failure caused by Wilson's disease from other types of fulminant hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001814     DOI: 10.1016/0016-5085(91)90294-u

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

1.  Wilson's disease presented with fulminating hepatic failure in children.

Authors:  A Yüce; N Koçak; F Gürakan; H Ozen
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Orthotopic liver transplantation in liver-based metabolic disorders.

Authors:  A P Mowat
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

3.  Liver transplantation for Wilson disease.

Authors:  Andreea M Catana; Valentina Medici
Journal:  World J Hepatol       Date:  2012-01-27

4.  Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests.

Authors:  Jessica D Korman; Irene Volenberg; Jody Balko; Joe Webster; Frank V Schiodt; Robert H Squires; Robert J Fontana; William M Lee; Michael L Schilsky
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

Review 5.  Insights into the management of Wilson's disease.

Authors:  Mohmadshakil Kathawala; Gideon M Hirschfield
Journal:  Therap Adv Gastroenterol       Date:  2017-10-03       Impact factor: 4.409

Review 6.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

7.  WILSON'S DISEASE (A report of two cases).

Authors:  M Kanitkar; S N JOSHi; N Dutta Roy
Journal:  Med J Armed Forces India       Date:  2017-06-27

Review 8.  Wilson's disease.

Authors:  Anand Pandit; Ashish Bavdekar; Sheila Bhave
Journal:  Indian J Pediatr       Date:  2002-09       Impact factor: 1.967

9.  [44-year-old patient with fulminant liver failure].

Authors:  A Kerber; C Sarrazin; C Allers; B Markus; K Engels; W Caspary; S Zeuzem
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

10.  Diagnostic criteria for acute liver failure due to Wilson disease.

Authors:  Christoph Eisenbach; Olivia Sieg; Wolfgang Stremmel; Jens Encke; Uta Merle
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.